Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
2008 Standout
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
2009 StandoutScience
Assessment of Myocardial Viability in Patients With Chronic Coronary Artery Disease
1996
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts
2019
Membrane curvature regulates the spatial distribution of bulky glycoproteins
2022 StandoutNobel
Why do cancers have high aerobic glycolysis?
2004 Standout
Nasopharyngeal carcinoma
2005 Standout
MET and VEGF: synergistic targets in castration-resistant prostate cancer
2011
Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis
2015
Prevalence and Patterns of Bone Metastases Detected with Positron Emission Tomography Using F-18 FDG
2003
Cancer to bone: a fatal attraction
2011 Standout
A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone‐refractory prostate cancer
2007
Imaging assessment of the responses of osteosarcoma patients to preoperative chemotherapy
1999
The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction
2000 Standout
Nomograms in oncology: more than meets the eye
2015 Standout
Pancreatic head cancer: accuracy of CT in determination of resectability
2005
O-Pair Search with MetaMorpheus for O-glycopeptide characterization
2020 StandoutNobel
The impact of fluor‐18‐deoxyglucose‐positron emission tomography in the management of colorectal liver metastases
2005
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
Prevalence of Anderson–Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson–Fabry Disease Survey
2011
Technetium-99m-labeled Myocardial Perfusion Agents: Are They Better than Thallium-201?
2001
Heritable and non-heritable uncommon causes of stroke
2020
Characterization of Small Solid Tumors in the Pancreas: The Value of Contrast-Enhanced Harmonic Endoscopic Ultrasonography
2011
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
2003 Standout
The development of androgen-independent prostate cancer
2001 Standout
A multigenic program mediating breast cancer metastasis to bone
2003 Standout
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems
2004 StandoutNobel
ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article
2002 Standout
Cardiovascular and musculoskeletal response to supervised exercise in patients with intermittent claudication
2018 StandoutNobel
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Fate and long-term prognostic implications of mitral regurgitation in patients undergoing transcatheter aortic valve replacement
2019
Immunopathology of multiple sclerosis
2015 Standout
Revealing the human mucinome
2022 StandoutNobel
Strategies for early detection of resectable pancreatic cancer
2014
Plasma osteopontin
2002
Treatment of congestive heart failure with coenzyme Q10 Illuminated by meta-analyses of clinical trials
1997
Glycosylation in health and disease
2019
Immunotherapy for prostate cancer
2006
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Microtubules as a target for anticancer drugs
2004 Standout
Pancreatic Cancer
2010 Standout
CT and 18F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers
2001
Current status of ECG stress testing
1998
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
Using Positron Emission Tomography with [18F]FDG to Predict Tumor Behavior in Experimental Colorectal Cancer
2001
MicroRNAs in Cardiovascular Disease
2016
PET-CT–Based Auto-Contouring in Non–Small-Cell Lung Cancer Correlates With Pathology and Reduces Interobserver Variability in the Delineation of the Primary Tumor and Involved Nodal Volumes
2007
Exposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures
2009 Standout
Clinicians Versus Nomogram: Predicting Future Technetium-99m Bone Scan Positivity in Patients With Rising Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer
2013
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014 Standout
Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial results
2006 StandoutNobel
A phase I study of cabozantinib (XL184) in patients with renal cell cancer
2014 StandoutNobel
Immunotherapy for prostate cancer
2007
The Natural History of Noncastrate Metastatic Prostate Cancer after Radical Prostatectomy
2006
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Resistance of [ 18 F]-Fluorodeoxyglucose-Avid Metastatic Thyroid Cancer Lesions to Treatment with High-Dose Radioactive Iodine
2001
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Nanomaterials for In Vivo Imaging
2017
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Enzyme replacement therapy for Anderson-Fabry disease
2016
Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.
2004
Intensity of18Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin’s Lymphoma
2005
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
2018 Standout
Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomographic Scanning in Patients with Thyroid Cancer
2000
Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers.
1998
Diabetic Cardiomyopathy
2018 Standout
Electron-Based Dissociation Is Needed for O-Glycopeptides Derived from OpeRATOR Proteolysis
2020 StandoutNobel
Survival and Cardiovascular Outcomes of Patients With Secondary Mitral Regurgitation
2017
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
The Development of the α-Particle Emitting Radionuclides 212Bi and 213Bi, and Their Decay Chain Related Radionuclides, for Therapeutic Applications
2001
Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer.
2004
Colorectal cancer statistics, 2017
2017 Standout
Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer
2007
Extracellular Calcium as a Candidate Mediator of Prostate Cancer Skeletal Metastasis
2006
Nomogram for Overall Survival of Patients With Progressive Metastatic Prostate Cancer After Castration
2002
Bone Turnover Mediates Preferential Localization of Prostate Cancer in the Skeleton
2005
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Spontaneous delayed recovery of perfusion and contraction after the first 5 weeks after anterior infarction. Evidence for the presence of hibernating myocardium in the infarcted area.
1994
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
2013
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
2006 Standout
Dose escalation study of intravenous estramustine phosphate in combination with Paclitaxel and Carboplatin in patients with advanced prostate cancer.
2003
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
2005
Novel strategies and therapeutics for the treatment of prostate carcinoma
2000
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
6-[F-18]Fluoro-l -Dihydroxyphenylalanine Positron Emission Tomography Is Superior to Conventional Imaging with 123I-Metaiodobenzylguanidine Scintigraphy, Computer Tomography, and Magnetic Resonance Imaging in Localizing Tumors Causing Catecholamine Excess
2009
Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication
2015
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Works of Massimo Imbriaco being referenced
Effects of Switching from Agalsidase Beta to Agalsidase Alfa in 10 Patients with Anderson-Fabry Disease
2012
Rest-injected thallium-201 redistribution and resting technetium-99m methoxyisobutylisonitrile uptake in coronary artery disease: relation to the severity of coronary artery stenosis
1993
Redefining the Pulvinar Sign in Fabry Disease
2017
Effects of enzyme-replacement therapy in patients with Anderson–Fabry disease: a prospective long-term cardiac magnetic resonance imaging study
2009
Multidetector row CT angiography of the abdominal aorta and lower extremities in patients with peripheral arterial occlusive disease: diagnostic accuracy and interobserver agreement
2003
Cardiac magnetic resonance imaging illustrating Anderson–Fabry disease progression
2010
Meta-Analysis of Mortality Outcomes and Mitral Regurgitation Evolution in 4,839 Patients Having Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis
2014
Detection of bony metastases of androgen-independent prostate cancer by PET-FDG
1996
Noninvasive evaluation of cardiac hemodynamics during exercise in patients with chronic heart failure: Effects of short-term Coenzyme Q10 treatment
1994
Circulating miR-29a, Among Other Up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients With Hypertrophic Cardiomyopathy
2013
Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding
1997
Enzyme replacement therapy in patients with Fabry disease: State of the art and review of the literature
2012
Role of cardiac MRI in evaluating patients with Anderson-Fabry disease: assessing cardiac effects of long-term enzyme replacement therapy
2011
Meta-Analysis of Effect of Body Mass Index on Outcomes After Transcatheter Aortic Valve Implantation
2016
Comparison between multislice CT and MR imaging in the diagnostic evaluation of patients with pancreatic masses
2010
Dual-Phase Versus Single-Phase Helical CT to Detect and Assess Resectability of Pancreatic Carcinoma
2002
Reverse redistribution in resting thallium-201 myocardial scintigraphy in patients with coronary artery disease: relation to coronary anatomy and ventricular function.
1993
Value of the Single-Phase Technique in MDCT Assessment of Pancreatic Tumors
2005
Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding
1997
Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease.
1995
Quantitative bone metastases analysis based on image segmentation.
1997
Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma
1997
Myocardial viability index in chronic coronary artery disease: technetium-99m-methoxy isobutyl isonitrile redistribution.
1995
Whole-Body FDG-PET in Patients with Recurrent Colorectal Carcinoma A Comparative Study with CT
2000
Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media.
2014
A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index.
1998
Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer.
1998
Growth Hormone Deficiency in Patients with Chronic Heart Failure and Beneficial Effects of Its Correction
2009
Prognostic Significance of Extent of Disease in Bone in Patients With Androgen-Independent Prostate Cancer
1999